Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Togashi

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Journal for Immunotherapy of Cancer|September 15, 2019
Clinical and immune profiling for cancer of unknown primary siteKoji Haratani, Hidetoshi Hayashi, Takayuki Takahama, et al.
The Journal of Investigative Dermatology|March 16, 2026
Blockade for CD276-mediated suppression of tumor-specific CTLs may contribute to achieving durable responses with immune checkpoint inhibitorsKazuhiro Aoyama, Shusuke Kawashima, Yuka Saeki, et al.
Communications Biology|November 23, 2021
Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancerShinichi Namba, Toshihide Ueno, Shinya Kojima, et al.
Cancer|October 22, 2015
Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomasYasumasa Yoshioka, Yosuke Togashi, Takaaki Chikugo, et al.
Cancer Science|September 2, 2016
FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanibMasaaki Hibi, Hiroyasu Kaneda, Junko Tanizaki, et al.
Cancer Research Communications|January 13, 2026
Clinical characteristics and spatial transcriptome analysis of non-small cell lung cancers exhibiting early alectinib resistance: a retrospective OLCSG studyTadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi, et al.
Cancer Immunology Research|November 27, 2024
The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor MicroenvironmentAyaka Tsuge, Sho Watanabe, Akihito Kawazoe, et al.
Oncotarget|May 10, 2014
Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinomaHidetoshi Hayashi, Tokuzo Arao, Kazuko Matsumoto, et al.
Cancer Science|April 14, 2015
Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC StudyHiroki Yamaue, Takuya Tsunoda, Masaji Tani, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2025
Endotracheal and Endobronchial Metastases in Epidermal Growth Factor Receptor Exon 19 Deletion Lung Adenocarcinoma: A Case Successfully Managed with Bronchoscopic Therapy and Sequential Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsMiho Fujiwara, Takahiro Baba, Kotaro Yamada, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|September 15, 2019
Clinical and immune profiling for cancer of unknown primary siteKoji Haratani, Hidetoshi Hayashi, Takayuki Takahama, et al.
The Journal of Investigative Dermatology|March 16, 2026
Blockade for CD276-mediated suppression of tumor-specific CTLs may contribute to achieving durable responses with immune checkpoint inhibitorsKazuhiro Aoyama, Shusuke Kawashima, Yuka Saeki, et al.
Communications Biology|November 23, 2021
Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancerShinichi Namba, Toshihide Ueno, Shinya Kojima, et al.
Cancer|October 22, 2015
Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomasYasumasa Yoshioka, Yosuke Togashi, Takaaki Chikugo, et al.
Cancer Science|September 2, 2016
FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanibMasaaki Hibi, Hiroyasu Kaneda, Junko Tanizaki, et al.
Cancer Research Communications|January 13, 2026
Clinical characteristics and spatial transcriptome analysis of non-small cell lung cancers exhibiting early alectinib resistance: a retrospective OLCSG studyTadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi, et al.
Cancer Immunology Research|November 27, 2024
The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor MicroenvironmentAyaka Tsuge, Sho Watanabe, Akihito Kawazoe, et al.
Oncotarget|May 10, 2014
Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinomaHidetoshi Hayashi, Tokuzo Arao, Kazuko Matsumoto, et al.
Cancer Science|April 14, 2015
Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS-PC StudyHiroki Yamaue, Takuya Tsunoda, Masaji Tani, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2025
Endotracheal and Endobronchial Metastases in Epidermal Growth Factor Receptor Exon 19 Deletion Lung Adenocarcinoma: A Case Successfully Managed with Bronchoscopic Therapy and Sequential Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsMiho Fujiwara, Takahiro Baba, Kotaro Yamada, et al.
Pageof 16